Morrison & Foerster is representing Temasek, a Singapore-based investment firm, in its significant investment in Verily Life Sciences, an Alphabet company. The companies intend to commercialize healthcare solutions for global markets. Temasek has an estimated US$180 billion portfolio that covers a broad spectrum of sectors: telecommunications, media & technology; financial services; transportation & industrials; consumer & real estate; life sciences & agriculture; energy & resources. Its investment themes reflect Temasek’s perspectives on long term trends: transforming economies, growing middle income populations, deepening comparative advantages, and emerging champions. Verily, formerly known as Google Life Sciences, is a life sciences research and engineering organization focused on improving healthcare outcomes by applying the latest scientific and technological advances to significant problems in health and biology.
San Francisco corporate partners Susan Mac Cormac and Alfredo Silva lead the Morrison & Foerster deal team. The team also includes San Francisco corporate partner Robert Townsend, San Diego patent partner James Mullen, San Francisco technology transactions partner Paul Jahn, San Francisco tax partner Bernie Pistillo and Palo Alto privacy partner Christine Lyon, San Francisco technology transactions of counsel Cara Ann Marr Rydbeck and associates Can Cui and Kelly Lowenberg, San Francisco benefits of counsels Amanda Hines Gold and Ali Nardali, Northern Virginia patent associate Shouvik Biswas, San Francisco corporate associates Jesse Finfrock and Jonathan O’Connell, New York privacy associate Melissa Crespo and New York corporate associate Ben Fox.
For more information, see the company’s press release.
Select media coverage: